1. Home
  2. KOPN vs STRO Comparison

KOPN vs STRO Comparison

Compare KOPN & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kopin Corporation

KOPN

Kopin Corporation

HOLD

Current Price

$5.04

Market Cap

396.8M

Sector

Technology

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$38.81

Market Cap

338.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOPN
STRO
Founded
1984
2003
Country
United States
United States
Employees
N/A
131
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
396.8M
338.9M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
KOPN
STRO
Price
$5.04
$38.81
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$4.69
$31.33
AVG Volume (30 Days)
11.6M
211.2K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
103.03
N/A
EPS
N/A
N/A
Revenue
$1,530,311.00
N/A
Revenue This Year
$50.07
N/A
Revenue Next Year
$33.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
46.53
N/A
52 Week Low
$1.23
$0.67
52 Week High
$6.45
$41.88

Technical Indicators

Market Signals
Indicator
KOPN
STRO
Relative Strength Index (RSI) 62.85 64.55
Support Level $2.05 $10.50
Resistance Level N/A N/A
Average True Range (ATR) 0.68 3.42
MACD 0.03 -0.20
Stochastic Oscillator 54.19 63.89

Price Performance

Historical Comparison
KOPN
STRO

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: